glp-1 drugs news The popularity of has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects GLP-1s like Ozempic are among

2.3 Neuroinflammation and cognitive dysfunction in diabetes Diabetes, as a chronic metabolic disorder, induces a chronic inflammatory state that damages the central nervous system

The current therapeutic paradigm for diabetes management entails a comprehensive, multi-modal strategy encompassing both lifestyle and pharmacological interventions

Tablets such as Rybelsus can be effective but often produce slightly less weight loss than injectable forms like Wegovy or Mounjaro

2024, doi: 10.1111/dom.15869

Licensing trials for Semaglutide (the active ingredient in Ozempic) showed better results than later real-world trials

Most insurance plans cover GLP-1 medications only when prescribed for diabetes or, in some cases, obesity with specific BMI criteria